Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2025-03-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
独立董事述职报告（陈彦晶）
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of 九芝堂股份有限公司 for the year 2024. It includes information about the director's background, attendance at board and committee meetings, voting records, communication with auditors and shareholders, site visits, and overall evaluation of their duties. The content focuses on governance, compliance with laws and regulations, and the director's role in oversight and decision-making. It is not a financial report, earnings release, or a simple announcement. It is a management-related report specifically about the independent director's annual duties and performance, which fits best under Board/Management Information (MANG). The document length is 3776 characters, which is sufficient for a substantive report rather than a brief announcement. There is no indication that this is a proxy statement, remuneration report, or regulatory filing. Therefore, the classification is MANG with high confidence.
2025-03-27 Chinese
董事会对独立董事独立性评估的专项意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of 九芝堂股份有限公司 regarding the independence of its independent directors. It references regulatory guidelines related to independent directors and confirms their compliance with independence requirements. The document is short (601 characters) and does not contain financial statements or detailed financial data. It is not a full report but a specific board/management announcement about director independence. Therefore, it fits best under Board/Management Information (MANG).
2025-03-27 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled "九芝堂股份有限公司2024 年年度报告全文" which translates to "Jiuzhitang Co., Ltd. 2024 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, governance, social responsibility, and financial statements. The document includes comprehensive financial figures for the year 2024, management commentary, business overview, and audit information references. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial data and management analysis confirms it is the official yearly report covering company activity and full financial performance, consistent with the definition of an Annual Report (10-K). FY 2024
2025-03-27 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2024 by 九芝堂股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial control defect standards, evaluation scope, and conclusions about the effectiveness of internal controls as of December 31, 2024. The document is a detailed report on internal control effectiveness rather than a brief announcement or a certification. It does not fit the categories of Annual Report (10-K), Interim Report (IR), or Audit Report (AR) exactly, but it is a standalone report focused on internal control evaluation, which aligns with the Audit Report / Information (AR) category as it relates to internal control and audit-related information. The document length is 3223 characters, which is substantial but not extremely long, consistent with a standalone audit-related report rather than a full annual report. Therefore, the best classification is AR (Audit Report / Information). FY 2024
2025-03-27 Chinese
第九届董事会独立董事专门会议第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions from a specific board meeting of 九芝堂股份有限公司, specifically the independent directors' meeting. It includes voting results on matters such as confirmation of related party transactions and application to remove risk warnings. It references audit reports but does not contain the audit reports themselves or detailed financial data. The document is short (1347 characters) and serves as a formal announcement of board decisions rather than a full report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2025-03-27 Chinese
独立董事述职报告（张劲松）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director (张劲松) of 九芝堂股份有限公司 for the year 2024. It includes descriptions of the director's duties, attendance at board and committee meetings, communication with auditors, and oversight activities. The content focuses on governance, director responsibilities, and compliance with corporate governance rules. It is not a financial report, earnings release, or regulatory filing but rather a management/board-related report specifically about the independent director's annual work and duties. This fits best under Board/Management Information (MANG) as it relates to board member activities and governance roles.
2025-03-27 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.